𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enhancement of radiotherapy with DNA topoisomerase I-targeted drugs

✍ Scribed by Allan Y. Chen; Rachel Chou; Shyh-Jen Shih; Derick Lau; David Gandara

Book ID
108110018
Publisher
Elsevier Science
Year
2004
Tongue
English
Weight
176 KB
Volume
50
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

High antineoplastic activity of new hete
High antineoplastic activity of new heterocyclic compounds in cancer cells with resistance against classical DNA topoisomerase II-targeting drugs
✍ Hermann Lage; Esin Aki-Sener; Ismail Yalcin πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 237 KB

## Abstract Twenty previously synthesized fused heterocyclic DNA‐topoisomerase II (Topo II)‐inhibiting compounds were investigated for their potential efficacy in various human cancer cell lines that were derived from different tumor entities. Moreover, different multidrug‐resistant variants of the

Interaction of clinically important huma
Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA
✍ Sergei Streltsov; Vladimir Oleinikov; Mikhail Ermishov; Konstantin Mochalov; Aly πŸ“‚ Article πŸ“… 2003 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 201 KB πŸ‘ 1 views

## Abstract Topotecan (TPT), a water‐soluble derivative of camptothecin, is a potent antitumor poison of human DNA topoisomerase I (top1) that stabilizes the cleavage complex between the enzyme and DNA. The role of the recently discovered TPT affinity to DNA remains to be defined. The aim of this w